Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse
In this study among dialysis patients, about 1 in every 3 SARS-CoV-2 infections were undiagnosed
https://t.co/X8RedXPSej
🚨🚨🚨NEW DART TRIAL PAPER! A brief tweetorial: Older patients with advanced CK) face difficult decisions about managing kidney failure, frequently experiencing decisional conflict, regret, and treatment misaligned with preferences.
@PCORI@AnnalsofIM@tuftsctsi@TuftsMCKidney
🚨🚨🚨NEW DART TRIAL PAPER! A brief tweetorial: Older patients with advanced CK) face difficult decisions about managing kidney failure, frequently experiencing decisional conflict, regret, and treatment misaligned with preferences.
@PCORI@AnnalsofIM@tuftsctsi@TuftsMCKidney
Editorial on work from UM-KECC in @KidneyMed on COVID, dialysis and quality metrics from @AliCookReaves and @CarolineMHsu of @TuftsMCKidney and @tuftsctsi - they did a phenomenal job of discussing how to assess quality in dialysis in the Covid era. https://t.co/paep2bQPec
Congrats @McCallumMD for a Charlton grant award from @TuftsMedSchool to study Ultrasound-guided Evaluation of Intrarenal Congestion in Chronic HF. Charlton grants provide support to develop research tools/collect preliminary data that lead to extramural funding
@eric_weinhandl@PD_Perls I think controlling transmission within the dialysis center is achievable, but it takes a lot - masking, and rigorous screening for symptoms and prompt testing (or just surveillance testing), then clustering cases together. Things we were learning on the fly for a while
@eric_weinhandl@PD_Perls Oh wow, that’s a bigger difference by modality than I’ve seen. Transmission within the dialysis center and shared transportation are real issues